GB0312832D0 - 2-amino-pyridine derivatives useful for the treatment of diseases - Google Patents

2-amino-pyridine derivatives useful for the treatment of diseases

Info

Publication number
GB0312832D0
GB0312832D0 GBGB0312832.9A GB0312832A GB0312832D0 GB 0312832 D0 GB0312832 D0 GB 0312832D0 GB 0312832 A GB0312832 A GB 0312832A GB 0312832 D0 GB0312832 D0 GB 0312832D0
Authority
GB
United Kingdom
Prior art keywords
diseases
amino
treatment
pyridine derivatives
derivatives useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0312832.9A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd Great Britain
Pfizer Inc
Original Assignee
Pfizer Ltd Great Britain
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd Great Britain, Pfizer Inc filed Critical Pfizer Ltd Great Britain
Priority to GBGB0312832.9A priority Critical patent/GB0312832D0/en
Publication of GB0312832D0 publication Critical patent/GB0312832D0/en
Priority to DE602004008773T priority patent/DE602004008773T2/de
Priority to BRPI0410946-5A priority patent/BRPI0410946A/pt
Priority to PE2004000553A priority patent/PE20050628A1/es
Priority to ES04735621T priority patent/ES2291882T3/es
Priority to CA002527788A priority patent/CA2527788A1/en
Priority to MXPA05012840A priority patent/MXPA05012840A/es
Priority to PCT/IB2004/001850 priority patent/WO2004108676A1/en
Priority to EP04735621A priority patent/EP1633715B1/en
Priority to AT04735621T priority patent/ATE372321T1/de
Priority to JP2006508431A priority patent/JP2006526613A/ja
Priority to UY28339A priority patent/UY28339A1/es
Priority to TW093115990A priority patent/TW200524603A/zh
Priority to PA20048604301A priority patent/PA8604301A1/es
Priority to GT200400116A priority patent/GT200400116A/es
Priority to CL200401366A priority patent/CL2004001366A1/es
Priority to US10/860,772 priority patent/US7375100B2/en
Priority to ARP040101904A priority patent/AR044475A1/es
Priority to NL1026329A priority patent/NL1026329C2/nl
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GBGB0312832.9A 2003-06-04 2003-06-04 2-amino-pyridine derivatives useful for the treatment of diseases Ceased GB0312832D0 (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
GBGB0312832.9A GB0312832D0 (en) 2003-06-04 2003-06-04 2-amino-pyridine derivatives useful for the treatment of diseases
BRPI0410946-5A BRPI0410946A (pt) 2003-06-04 2004-06-01 derivados de 2-(6-amino-piridin-3-il)-2-hidroxietilamina como agonistas de receptores adrenérgicos beta 2
EP04735621A EP1633715B1 (en) 2003-06-04 2004-06-01 2-(6-amino-pyridin-3-yl)-2-hydroxyethylamine derivatives as beta 2-adrenoceptors agonists
JP2006508431A JP2006526613A (ja) 2003-06-04 2004-06-01 β２−アドレナリン受容体アゴニストとしての２−（６−アミノ−ピリジン−３−イル）−２−ヒドロキシエチルアミン誘導体
PE2004000553A PE20050628A1 (es) 2003-06-04 2004-06-01 DERIVADOS DE 2-AMINO-PIRIDINA COMO AGONISTAS ß-2
ES04735621T ES2291882T3 (es) 2003-06-04 2004-06-01 Derivados de 2-(6-amino-piridin-3-il)-2-hidroxietilamina como agonistas de adrenoceptores beta 2.
CA002527788A CA2527788A1 (en) 2003-06-04 2004-06-01 2-(6-amino-pyridin-3-yl)-2-hydroxyethylamine derivatives as beta 2-adrenoceptors agonists
MXPA05012840A MXPA05012840A (es) 2003-06-04 2004-06-01 Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades.
PCT/IB2004/001850 WO2004108676A1 (en) 2003-06-04 2004-06-01 2-(6-amino-pyridin-3-yl)-2-hydroxyethylamine derivatives as beta 2-adrenoceptors agonists
DE602004008773T DE602004008773T2 (de) 2003-06-04 2004-06-01 2-(6-amino-pyridin-3-yl)-2-hydroxyethylamin-verbindungen als beta 2-adrenoceptoren agonisten
AT04735621T ATE372321T1 (de) 2003-06-04 2004-06-01 2-(6-amino-pyridin-3-yl)-2-hydroxyethylamin- verbindungen als beta 2-adrenoceptoren agonisten
UY28339A UY28339A1 (es) 2003-06-04 2004-06-02 Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades
NL1026329A NL1026329C2 (nl) 2003-06-04 2004-06-03 2-Amino-pyridinederivaten toepasbaar voor de behandeling van ziekten.
TW093115990A TW200524603A (en) 2003-06-04 2004-06-03 2-amino-pyridine derivatives useful for the treatment of diseases
PA20048604301A PA8604301A1 (es) 2003-06-04 2004-06-03 Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades
GT200400116A GT200400116A (es) 2003-06-04 2004-06-03 Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades.
CL200401366A CL2004001366A1 (es) 2003-06-04 2004-06-03 Compuestos derivados de 2-(6-amino-piridin-2-il)-2-hidroxietilamino sustituidos, agonistas b2-adrenoceptores; procedimiento de preparacion; composicion farmaceutica; composicion farmaceutica y uso del compuesto en el tratamiento de asma, bronquitis c
US10/860,772 US7375100B2 (en) 2003-06-04 2004-06-03 2-amino-pyridine derivatives useful for the treatment of diseases
ARP040101904A AR044475A1 (es) 2003-06-04 2004-06-03 Derivados de 2-amino -piridina utiles para el tratamiento de enfermedades

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0312832.9A GB0312832D0 (en) 2003-06-04 2003-06-04 2-amino-pyridine derivatives useful for the treatment of diseases

Publications (1)

Publication Number Publication Date
GB0312832D0 true GB0312832D0 (en) 2003-07-09

Family

ID=9959308

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0312832.9A Ceased GB0312832D0 (en) 2003-06-04 2003-06-04 2-amino-pyridine derivatives useful for the treatment of diseases

Country Status (18)

Country Link
EP (1) EP1633715B1 (https=)
JP (1) JP2006526613A (https=)
AR (1) AR044475A1 (https=)
AT (1) ATE372321T1 (https=)
BR (1) BRPI0410946A (https=)
CA (1) CA2527788A1 (https=)
CL (1) CL2004001366A1 (https=)
DE (1) DE602004008773T2 (https=)
ES (1) ES2291882T3 (https=)
GB (1) GB0312832D0 (https=)
GT (1) GT200400116A (https=)
MX (1) MXPA05012840A (https=)
NL (1) NL1026329C2 (https=)
PA (1) PA8604301A1 (https=)
PE (1) PE20050628A1 (https=)
TW (1) TW200524603A (https=)
UY (1) UY28339A1 (https=)
WO (1) WO2004108676A1 (https=)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0411056D0 (en) 2004-05-18 2004-06-23 Novartis Ag Organic compounds
PE20060272A1 (es) 2004-05-24 2006-05-22 Glaxo Group Ltd (2r,3r,4s,5r,2'r,3'r,4's,5's)-2,2'-{trans-1,4-ciclohexanodiilbis-[imino(2-{[2-(1-metil-1h-imidazol-4-il)etil]amino}-9h-purin-6,9-diil)]}bis[5-(2-etil-2h-tetrazol-5-il)tetrahidro-3,4-furanodiol] como agonista a2a
UA87854C2 (en) 2004-06-07 2009-08-25 Мерк Энд Ко., Инк. N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
MX2007003332A (es) 2004-09-20 2007-06-05 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como inhibidores de estearoil-coa-desaturasa.
MX2007003318A (es) 2004-09-20 2007-05-18 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como agentes terapeuticos.
BRPI0515482A (pt) 2004-09-20 2008-07-22 Xenon Pharmaceuticals Inc derivados heterocìclicos e seus usos como agentes terapêuticos
AU2005286728A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
BRPI0515500A (pt) 2004-09-20 2008-07-29 Xenon Pharmaceuticals Inc derivados piridazina para inibição de estearoil-coa-desaturase
CN101084211A (zh) 2004-09-20 2007-12-05 泽农医药公司 杂环衍生物及其作为治疗剂的用途
AU2005286647A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
GT200500281A (es) 2004-10-22 2006-04-24 Novartis Ag Compuestos organicos.
GB0424284D0 (en) 2004-11-02 2004-12-01 Novartis Ag Organic compounds
GB0426164D0 (en) 2004-11-29 2004-12-29 Novartis Ag Organic compounds
CA2618646A1 (en) 2005-06-03 2007-11-15 Xenon Pharmaceuticals Inc. Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
GB0516313D0 (en) 2005-08-08 2005-09-14 Argenta Discovery Ltd Azole derivatives and their uses
JP2009504624A (ja) 2005-08-08 2009-02-05 アージェンタ ディスカバリー リミテッド ビシクロ［２．２．１］ヘプタ−７−イルアミン誘導体およびその使用
WO2007045477A2 (en) 2005-10-21 2007-04-26 Novartis Ag Human antibodies against il-13 and therapeutic uses
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
PT2322525E (pt) 2006-04-21 2013-12-26 Novartis Ag Derivados de purina para utilização como agonistas do recetor de adenosina a2a
PT2035004E (pt) * 2006-06-09 2012-11-21 Parion Sciences Inc Bloqueadores dos canais de sódio de pirazinoilguanidona substituída com fenilo que possuem actividade agonista beta
EP2535330A3 (en) 2006-10-23 2012-12-26 Takeda Pharmaceutical Company Limited Iminopyridine derivative and use thereof
CN101687851B (zh) 2007-05-07 2013-02-27 诺瓦提斯公司 有机化合物
CL2008003651A1 (es) 2007-12-10 2009-06-19 Novartis Ag Compuestos derivados de 3,5-diamino-6-cloropirazinamida sustituida; composicion farmaceutica; combinacion farmaceutica; y uso en el tratamiento de una condición inflamatoria o alergica, en particular una enfermedad inflamatoria u obstructiva de las vias respiratorias.
AU2009203693B2 (en) 2008-01-11 2012-06-07 Novartis Ag Pyrimidines as kinase inhibitors
US8481569B2 (en) 2008-04-23 2013-07-09 Takeda Pharmaceutical Company Limited Iminopyridine derivatives and use thereof
CA2727196A1 (en) 2008-06-10 2009-12-17 Novartis Ag Organic compounds
US8236786B2 (en) 2008-08-07 2012-08-07 Pulmagen Therapeutics (Inflammation) Limited Respiratory disease treatment
DE102008049675A1 (de) 2008-09-30 2010-04-01 Markus Dr. Heinrich Verfahren zur Herstellung von 3-Aminobiphenylen
MX2011007036A (es) 2008-12-30 2011-07-20 Pulmagen Therapeutics Inflammation Ltd Compuestos de sulfonamida para el tratamiento de trastornos respiratorios.
WO2010150014A1 (en) 2009-06-24 2010-12-29 Pulmagen Therapeutics (Inflammation) Limited 5r- 5 -deuterated glitazones for respiratory disease treatment
US20110098311A1 (en) 2009-10-22 2011-04-28 Vertex Pharmaceuticals Incorported Compositions for treatment of cystic fibrosis and other chronic diseases
GB0918924D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Azaindole derivatives
GB0918923D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Aminothiazole derivatives
GB0918922D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Aminopyridine derivatives
WO2011098746A1 (en) 2010-02-09 2011-08-18 Pulmagen Therapeutics (Inflammation) Limited Crystalline acid addition salts of ( 5r) -enanti0mer of pioglitazone
GB201002224D0 (en) 2010-02-10 2010-03-31 Argenta Therapeutics Ltd Respiratory disease treatment
GB201002243D0 (en) 2010-02-10 2010-03-31 Argenta Therapeutics Ltd Respiratory disease treatment
US8247436B2 (en) 2010-03-19 2012-08-21 Novartis Ag Pyridine and pyrazine derivative for the treatment of CF
WO2012034095A1 (en) 2010-09-09 2012-03-15 Irm Llc Compounds and compositions as trk inhibitors
UY33597A (es) 2010-09-09 2012-04-30 Irm Llc Compuestos y composiciones como inhibidores de la trk
US8372845B2 (en) 2010-09-17 2013-02-12 Novartis Ag Pyrazine derivatives as enac blockers
MA34969B1 (fr) 2011-02-25 2014-03-01 Irm Llc Composes et compositions en tant qu inibiteurs de trk
US8883819B2 (en) 2011-09-01 2014-11-11 Irm Llc Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
WO2013038373A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine amide derivatives
WO2013038386A1 (en) 2011-09-16 2013-03-21 Novartis Ag Heterocyclic compounds for the treatment of cystic fibrosis
WO2013038381A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine/pyrazine amide derivatives
WO2013038378A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine amide derivatives
ES2882807T3 (es) 2011-09-16 2021-12-02 Novartis Ag Heterociclil carboxamidas N-sustituidas
US8809340B2 (en) 2012-03-19 2014-08-19 Novartis Ag Crystalline form
US9073921B2 (en) 2013-03-01 2015-07-07 Novartis Ag Salt forms of bicyclic heterocyclic derivatives
US9862711B2 (en) 2014-04-24 2018-01-09 Novartis Ag Pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
CA2945212A1 (en) 2014-04-24 2015-10-29 Novartis Ag Amino pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
BR112016024484A2 (pt) 2014-04-24 2017-08-15 Novartis Ag derivados de aminopiridina como inibidores de fosfatidilinositol 3-quinase
AU2020290094B2 (en) 2019-06-10 2024-01-18 Novartis Ag Pyridine and pyrazine derivative for the treatment of CF, COPD, and bronchiectasis
AU2020338971B2 (en) 2019-08-28 2023-11-23 Novartis Ag Substituted 1,3-phenyl heteroaryl derivatives and their use in the treatment of disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4358455A (en) * 1980-12-23 1982-11-09 Merck & Co., Inc. Aralkylamindethanol heterocyclic compounds
US5977124A (en) * 1995-05-10 1999-11-02 Pfizer Inc. β-adrenergic agonists
DE60015036T2 (de) * 1999-07-23 2006-03-02 Pfizer Products Inc., Groton Zwischenprodukte und ein Verfahren zur Herstellung von beta3-Adrenergischer Rezeptor-Agoniste
TWI249515B (en) * 2001-11-13 2006-02-21 Theravance Inc Aryl aniline beta2 adrenergic receptor agonists
GB0217225D0 (en) * 2002-07-25 2002-09-04 Glaxo Group Ltd Medicinal compounds
ES2302938T3 (es) * 2002-10-11 2008-08-01 Pfizer Inc. Derivados de indol como agonistas beta-2.

Also Published As

Publication number Publication date
BRPI0410946A (pt) 2006-06-27
AR044475A1 (es) 2005-09-14
EP1633715B1 (en) 2007-09-05
CA2527788A1 (en) 2004-12-16
WO2004108676A1 (en) 2004-12-16
ES2291882T3 (es) 2008-03-01
GT200400116A (es) 2005-03-03
MXPA05012840A (es) 2006-02-13
UY28339A1 (es) 2005-01-31
ATE372321T1 (de) 2007-09-15
DE602004008773D1 (de) 2007-10-18
DE602004008773T2 (de) 2008-01-10
JP2006526613A (ja) 2006-11-24
CL2004001366A1 (es) 2005-05-06
EP1633715A1 (en) 2006-03-15
NL1026329C2 (nl) 2005-07-26
TW200524603A (en) 2005-08-01
PA8604301A1 (es) 2004-12-16
NL1026329A1 (nl) 2004-12-07
PE20050628A1 (es) 2005-08-30

Similar Documents

Publication Publication Date Title
GB0312832D0 (en) 2-amino-pyridine derivatives useful for the treatment of diseases
SI1633726T1 (sl) Derivativi pirimidina, uporabni pri zdravljenju bolezni, posredovanih s crth 2
AP2005003283A0 (en) Indole derivatives useful for the treatment os diseases
SI1830843T1 (sl) Indolinonski derivati za zdravljenje ali preprečevanje fibroznih bolezni
PL362711A1 (en) Morpholin-acetamide derivatives for the treatment of inflammatory diseases
NL1026327A1 (nl) 2-Amino-pyridinederivaten toepasbaar voor de behandeling van ziekten.
NO20052894D0 (no) 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte
AP2006003671A0 (en) Sulfonamide derivatives for the treatment of diseases
IL184934A0 (en) 4-oxoquinazoline-3-yl-benzamide derivatives for the treatment of cytokine diseases
AP2006003669A0 (en) Sulfonamide derivatives for the treatment of diseases
GB0329874D0 (en) Compounds useful for the treatment of diseases
PL1685125T3 (pl) Pochodne pirrolowe użyteczne do leczenia chorób proliferacyjnych
SI1487828T1 (sl) Morfolinil-sečninski derivati za uporabo pri zdravljenu vnetnih bolezni
PL377164A1 (pl) Pochodne anilinopirazolu przydatne do leczenia cukrzycy
IL176472A (en) Process for the preparation of pyridine derivatives
IL165137A0 (en) Process for the preparation of thioalkylamine derivatives
GB0201025D0 (en) The treatment of degenerative diseases
GB0312840D0 (en) 2-amino-pyridine derivatives useful for the treatment of diseases
GB0312842D0 (en) 2-amino-pyridine derivatives useful for the treatment of diseases
GB0217205D0 (en) 2-Amino-pyridine derivatives useful for the treatment of diseases
AU2003232844A1 (en) Morpholin-acetamide derivatives for the treatment of inflammatory diseases
ZA200606780B (en) Compounds for the treatment of diseases
GB0425054D0 (en) Formamide derivatives for the treatment of diseases
IL175611A0 (en) Combinations for the treatment of proliferative diseases
HK1071754A (en) Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)